Cargando…

Combined use of circulating tumor cells and salivary mRNA to detect non–small-cell lung cancer

Liquid biopsy is an emerging technique for noninvasive detection of various cancers. Majority of liquid biopsy tests still, however, use solitary type of biomarkers with unsatisfactory sensitivity and specificity. To this end, a combined approach of circulating tumor cells (CTCs) and salivary mRNA b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Xianwen, He, Junfeng, Ji, Guanglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034687/ https://www.ncbi.nlm.nih.gov/pubmed/32080083 http://dx.doi.org/10.1097/MD.0000000000019097

Ejemplares similares

The effectiveness and safety of lienal polypeptide combined with chemotherapy or chemoradiotherapy for non-small cell lung cancer patients in real world
por: Wang, Zhe, et al.
Publicado: (2021)

Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis
por: Liu, Yafang, et al.
Publicado: (2016)

Mutation differences in circulating tumor DNAs from non-small cell lung cancer patients between Uygur and Han populations
por: Wang, Yuli, et al.
Publicado: (2021)

Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
por: Zhao, Chenchen, et al.
Publicado: (2021)

Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer: A PRISMA-compliant meta-analysis and systematic review
por: Zhou, Shunkai, et al.
Publicado: (2020)

Circulating tumor cells counts are associated with CD8+ T cell levels in programmed death-ligand 1-negative non-small cell lung cancer patients after radiotherapy: A retrospective study
por: Liu, Qingyun, et al.
Publicado: (2021)

A rapid response of lung squamous cell carcinoma following treatment with sintilimab combined with recombinant humane endostatin injection and nab-paclitaxel in an elderly patient: A case report
por: Fang, Yueyu, et al.
Publicado: (2021)

Effect of phenotypic detection of circulating tumor cells marked by epithelial-mesenchymal transformation on the prognosis of lung cancer: A protocol for systematic review and meta-analysis
por: Ge, Bin, et al.
Publicado: (2020)

Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer
por: Li, Fanghua, et al.
Publicado: (2023)

Dramatic response to osimertinib combined with crizotinib in EGFR T790 M mutation only in blood and Met amplification only in tumor tissue expressive non-small cell lung cancer: A case report
por: Li, Dapeng, et al.
Publicado: (2021)

Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer: A case report
por: Liu, Liang, et al.
Publicado: (2021)

The clinicopathological and prognostic significance of mTOR and p-mTOR expression in patients with non-small cell lung cancer: A meta-analysis
por: Qiu, Weiwei, et al.
Publicado: (2022)

Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report
por: Jin, Yonglong, et al.
Publicado: (2021)

Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis
por: Hu, Yongqi, et al.
Publicado: (2022)

Change in expressional level and clinicopathological significance of miR-193b-3p in non-small cell lung cancer
por: Xiao, Feng, et al.
Publicado: (2023)

Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients
por: Qiu, Lupeng, et al.
Publicado: (2020)

Responses to crizotinib and disease monitoring with circulating tumor cells in lung adenocarcinoma patient with MET exon 14 skipping mutation: A case report
por: Tan, Xiang, et al.
Publicado: (2017)

Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer
por: Lu, Huiling, et al.
Publicado: (2023)

Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
por: Chen, Mu-Tong, et al.
Publicado: (2023)

Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer
por: Liang, Wenjun, et al.
Publicado: (2016)

A real-world study of recombinant human endostatin combined with PD-1/PD-L1 blockade and chemotherapy for patients with advanced non-small cell lung cancer negative for actionable molecular biomarkers
por: Zhao, Jing-Wen, et al.
Publicado: (2023)

Combination therapy with afatinib and bevacizumab in an EGFR-mutated non-small cell lung cancer patient with acquired ERBB2 amplification: A case report
por: Chen, Sixian, et al.
Publicado: (2021)

Case report: pathological complete response in an IIIB non-small cell lung cancer patient after preoperative neoadjuvant nivolumab therapy combined with chemotherapy
por: Li, Luzhen, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy
por: Kutlu, Yasin, et al.
Publicado: (2023)

Small cell lung cancer treated by radiofrequency ablation: A case report
por: Song, Guo-qiang, et al.
Publicado: (2017)

Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer
por: Ye, Xiaolan, et al.
Publicado: (2020)

Maintenance treatment of combination with bevacizumab vs single agent for advanced non-squamous non-small cell lung cancer: A systematic review and meta-analysis
por: Kong, Ying, et al.
Publicado: (2021)

The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis
por: Sun, Chi, et al.
Publicado: (2017)

An integrated mRNA–lncRNA signature for overall survival prediction in cholangiocarcinoma
por: Xu, Derong, et al.
Publicado: (2023)

Synchronous diffuse large B-cell lymphoma of the stomach and small cell lung carcinoma: A case report
por: Li, Jia, et al.
Publicado: (2017)

High Incidence of EGFR Mutations in Pneumonic-Type Non-Small Cell Lung Cancer
por: Liu, Jun, et al.
Publicado: (2015)

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
por: Shen, Hong, et al.
Publicado: (2016)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

Analysis of immune subtypes in non-small-cell lung cancer based on TCGA database
por: Xie, Xuexue, et al.
Publicado: (2023)

Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches
por: Li, Hao, et al.
Publicado: (2015)

Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer
por: Lee, Dong Soo, et al.
Publicado: (2015)

A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients
por: Wu, Bo, et al.
Publicado: (2021)

Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review
por: Chen, Xiaoli, et al.
Publicado: (2023)

Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer
por: An, Yuzhi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dgprffp13a58sc2i6da7kqhmn1